Back

Evoq Remedies Ltd.

IPO Details · GMP · Subscription · Financials

✅ Listed BSE SME SME Live Chart
Issue Price
₹27
Per Share
GMP
NIL
Grey Market
Est. Listing
₹27
Expected Price
Min. Application
₹216,000
2 lots × 4000 shares
IPO Issue Details
Issue Price / Price Band₹27 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size4,000 Shares per Lot
Total Issue Size36,00,000 shares (aggregating up to ₹9.72 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenThu, 17 Mar 2022
Subscription CloseTue, 22 Mar 2022
Anchor AllotmentWed, 16 Mar 2022
Basis of AllotmentFri, 25 Mar 2022
Initiation of RefundsMon, 28 Mar 2022
Credit of Shares to DematTue, 29 Mar 2022
Listing DateWed, 30 Mar 2022
UPI Mandate Deadline2022-03-22
Application & Investment Details
Retail — Min (1 Lots)₹1,08,000 — 4,000 shares
Retail — Max (13 Lots)₹1,404,000 (13 Lots)
HNI — Min (2 Lots)₹2,16,000 — 8,000 shares
P/E Ratio (Pre-IPO)33.75x
Net Offer to Public34,20,000 shares (aggregating up to ₹9.23 Cr)
Reserved for Market Maker1,80,000 shares (aggregating up to ₹0.4860 Cr)
Pre-IPO Promoter Holding1,00,00,000 shares
Post-IPO Promoter Holding1,36,00,000 shares
About Evoq Remedies Ltd.

Incorporated in 2010, EVOQ Remedies Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company procures all the products from WHO-GMP certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards.Competitive strengths:Experienced Management Team.Continue to develop client relationships and Trust.Supplying the best quality products at the most reasonable prices.

Objects of the Issue

Evoq Remedies Ltd. proposes to utilise the net proceeds from the Issue for the following objects:

1
1 To Meet Incremental Working Capital Requirements
6.44
2
2 General Corporate Purpose
2.33
Shareholding & Lock-in
Pre-IPO Promoter Holding 1,00,00,000 shares
Post-IPO Promoter Holding 1,36,00,000 shares
Check AllotmentCheck Status →
Evoq Remedies Ltd. — Live Price LIVE
₹27.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Evoq Remedies Ltd. is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹27.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹27
GMPNIL
Est. Listing₹27
Lot Size4,000 shares
Min Amount₹216,000
Listing Date30 Mar 2022
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹27
Listing Date30 Mar 2022
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
Market Maker 180,000 ₹0.49 Cr
TOTAL 3,600,000 100.00% ₹9.72 Cr
* Based on ₹27.00 (upper price band)
Lot Size & Investment Details
Lot Size
4,000
Shares
Issue Price
₹27.00
Per Share
Min Investment
₹108,000
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 4,000 ₹108,000
Retail (Max) 13 52,000 ₹1,404,000
sNII (Min) 14 56,000 ₹1,512,000
bNII (Min) 68 272,000 ₹7,344,000
Company Financials — Restated Consolidated (Amount in Lakhs)
Particulars10-Feb-2231-Mar-2131-Mar-20
Revenue from Operations 1056.58 1002.48 907.21
EBITDA N/A N/A N/A
Profit After Tax (PAT) 93.67 71.38 0.03
Net Worth N/A N/A N/A
Total Assets 2660.58 804.63 565.22
Reserves & Surplus N/A N/A N/A
Total Borrowings N/A N/A N/A
Key Ratios & Valuation
Issue Price ₹27
Face Value ₹10 Per Share
P/BV N/A
RoE N/A
RoCE N/A
RoNW N/A
PAT Margin (%) N/A
EBITDA Margin (%) N/A
Debt / Equity N/A
Company Details
Company
Evoq Remedies Ltd.
Exchange
BSE SME
IPO Type
SME IPO
Issue Type
Fixed Price IPO
Face Value
₹10 Per Share
Script Code
N/A
Address
A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat, 380060
Book Running Lead Managers
Swastika Investmart Ltd.
Book Running Lead Manager (BRLM)